Boron neutron capture therapy for glioblastoma. Phase I/II clinical trial at JRR-4

A. Matsumura, T. Yamamoto, K. Nakai, H. Kumada, M. Matsuda & H. Sakurai
Objective: High dose irradiation to glioblastomas may improve the survival rate for glioblastomas. We have applied boron neutron capture therapy (BNCT) for newly diagnosed glioblastomas. BNCT is a cell selective alpha particle therapy produced by the nuclear reaction of 10B and the thermal neutron. [for full text, please go to the a.m. URL]